Additive Role of Low-intensity Extracorporeal Shock Wave Therapy to Kegel's Exercise in Management of Female Stress Urinary Incontinence : A Prospective Randomized Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 84
研究概览
简要总结
Stress urinary incontinence (SUI) is a common pelvic floor disorder among women, especially those with a history of childbirth, aging, or pelvic surgery. Stress urinary incontinence is defined as the complaint of involuntary leakage on effort or exertion, or on sneezing or coughing.
The condition significantly affects quality of life, emotional well-being, and daily functioning.
详细描述
Many women believe that urinary incontinence is an inevitable part of aging or the aftermath of childbirth and do not seek treatment because of embarrassment or a lack of knowledge about available therapies.
The main underlying mechanism of SUI is the weakening of the pelvic floor muscles and connective tissues supporting the bladder and urethra. This structural compromise leads to urethral hypermobility and insufficient urethral closure during physical strain.
Risk factors include vaginal delivery, menopause, obesity, and chronic respiratory conditions.
Effective treatment targets these musculoskeletal deficits to restore continence and reduce leakage episodes.
Kegel's exercise (KE), also known as pelvic floor muscle training, is the first-line conservative treatment for SUI. It involves repetitive contractions and relaxations of pelvic floor muscles to improve their strength, endurance, and coordination.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 25 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Married Females
- •Diagnosed with stress urinary incontinence, confirmed by clinical evaluation.
- •Ability and willingness to perform KE and attend follow-up visits.
- •Accepting informed consent.
排除标准
- •Mixed urinary incontinence.
- •Active urinary tract infection (symptomatic or laboratory) confirmed).
- •Known coagulopathy or ongoing anticoagulant therapy.
- •Neurological disorders (e.g., multiple sclerosis, stroke, spinal cord injury) or use of medications affecting bladder control.
- •Pregnancy or recent childbirth (within 6 months)
- •History of pelvic malignancy affecting urinary continence.
- •History of recent surgical intervention or indicated for surgery for urinary incontinence.
研究者
Abdelrhman Alshawadfy
Asisstant Professor
Suez Canal University